Literature DB >> 22783806

HIV infection risk among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan 2007-2010.

Yung-Feng Yen1, Timothy C Rodwell, Muh-Yong Yen, Yun-Hsia Hsu, Peing Chuang, Lan-Huei Li, Lien-Wen Su, Yi-Hong Yang, Xiao-Ru Jiang, Yung-Chun Fang, Richard S Garfein.   

Abstract

BACKGROUND: Taiwan has a growing HIV/AIDS epidemic that has recently shifted to an increase among injection drug users (IDUs). This study aimed to measure the prevalence and incidence and identify the correlates of HIV infection among IDUs in a large methadone maintenance treatment program (MMTP) in Taipei, Taiwan.
METHODS: Data from intake interviews and HIV testing completed by IDUs upon admission to the Taipei City Hospital MMTP in 2007-2010 were included in this analysis. HIV testing was repeated semi-annually among maintained clients who were HIV-negative during MMTP admission.
RESULTS: Of 1444 IDUs admitted, 85.9% were male, median age was 40 years, and mean years of injecting was 14.3 (range: 1-64). The prevalence of HIV, HCV, and HIV/HCV co-infection was 13.4%, 91.1%, and 13.2%, respectively. In multivariable analysis, HIV infection was associated with sharing syringes during the 6 months prior to admission (OR = 14.76, 95% CI 10.31-21.13), homelessness (OR = 6.46, 95% CI 1.49-28.00), and lifetime number of MMTP admissions (OR = 1.76, 95% CI 1.30-2.38) and times incarcerated (OR = 1.10, 95% CI 1.03-1.18). HIV seroincidence was 1.15/100 person-years at risk (95% CI .62-8.77/100 PY) among IDUs who were HIV-negative at first admission.
CONCLUSIONS: Taiwanese IDUs in MMTP have a high HIV prevalence, which was associated with syringe sharing and other factors related to social marginalization. Our findings highlight the importance of harm reduction programs, including syringe exchange, along with HIV-prevention education.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22783806      PMCID: PMC4229362          DOI: 10.3109/00952990.2012.702171

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  21 in total

1.  Survival of HIV-1 activity after disinfection, temperature and pH changes, or drying.

Authors:  E Tjøtta; O Hungnes; B Grinde
Journal:  J Med Virol       Date:  1991-12       Impact factor: 2.327

2.  Inactivation and survival of hepatitis C virus on inanimate surfaces.

Authors:  Juliane Doerrbecker; Martina Friesland; Sandra Ciesek; Thomas J Erichsen; Pedro Mateu-Gelabert; Jörg Steinmann; Jochen Steinmann; Thomas Pietschmann; Eike Steinmann
Journal:  J Infect Dis       Date:  2011-10-19       Impact factor: 5.226

3.  Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection drug users.

Authors:  R E Booth; T J Crowley; Y Zhang
Journal:  Drug Alcohol Depend       Date:  1996-09       Impact factor: 4.492

4.  Social-structural contexts of needle and syringe sharing behaviours of HIV-positive injecting drug users in Manipur, India: a mixed methods investigation.

Authors:  Venkatesan Chakrapani; Peter A Newman; Murali Shunmugam; Robert Dubrow
Journal:  Harm Reduct J       Date:  2011-05-13

5.  The effect of universal health insurance on health care utilization in Taiwan. Results from a natural experiment.

Authors:  S H Cheng; T L Chiang
Journal:  JAMA       Date:  1997-07-09       Impact factor: 56.272

6.  Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors.

Authors:  L Greenfield; G E Bigelow; R K Brooner
Journal:  Drug Alcohol Depend       Date:  1995-08       Impact factor: 4.492

7.  Methadone maintenance as HIV risk reduction with street-recruited injecting drug users.

Authors:  C F Kwiatkowski; R E Booth
Journal:  J Acquir Immune Defic Syndr       Date:  2001-04-15       Impact factor: 3.731

Review 8.  Systematic review of HIV and HCV infection among drug users in China.

Authors:  Y-P Bao; Z-M Liu
Journal:  Int J STD AIDS       Date:  2009-06       Impact factor: 1.359

9.  HIV seroprevalence in street youth, St. Petersburg, Russia.

Authors:  Dmitry M Kissin; Lauren Zapata; Roman Yorick; Elena N Vinogradova; Galina V Volkova; Elena Cherkassova; Allison Lynch; Jennifer Leigh; Denise J Jamieson; Polly A Marchbanks; Susan Hillis
Journal:  AIDS       Date:  2007-11-12       Impact factor: 4.177

10.  Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users.

Authors:  C A Latkin; D Vlahov
Journal:  Addiction       Date:  1998-08       Impact factor: 6.526

View more
  5 in total

1.  Homelessness and Other Risk Factors for HIV Infection in the Current Outbreak Among Injection Drug Users in Athens, Greece.

Authors:  Vana Sypsa; Dimitrios Paraskevis; Meni Malliori; Georgios K Nikolopoulos; Anastasios Panopoulos; Maria Kantzanou; Antigoni Katsoulidou; Mina Psichogiou; Anastasios Fotiou; Anastasia Pharris; Marita Van De Laar; Lucas Wiessing; Don Des Jarlais; Samuel R Friedman; Angelos Hatzakis
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

2.  Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme.

Authors:  Angelos Hatzakis; Vana Sypsa; Dimitrios Paraskevis; Georgios Nikolopoulos; Chrissa Tsiara; Katerina Micha; Anastasios Panopoulos; Meni Malliori; Mina Psichogiou; Anastasia Pharris; Lucas Wiessing; Marita van de Laar; Martin Donoghoe; Douglas D Heckathorn; Samuel R Friedman; Don C Des Jarlais
Journal:  Addiction       Date:  2015-07-14       Impact factor: 6.526

3.  Cancer risk factors among people living with HIV/AIDS in China: a systematic review and meta-analysis.

Authors:  Zi-Yi Jin; Xing Liu; Ying-Ying Ding; Zuo-Feng Zhang; Na He
Journal:  Sci Rep       Date:  2017-07-07       Impact factor: 4.379

4.  Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.

Authors:  Jack Stone; Hannah Fraser; Aaron G Lim; Josephine G Walker; Zoe Ward; Louis MacGregor; Adam Trickey; Sam Abbott; Steffanie A Strathdee; Daniela Abramovitz; Lisa Maher; Jenny Iversen; Julie Bruneau; Geng Zang; Richard S Garfein; Yung-Fen Yen; Tasnim Azim; Shruti H Mehta; Michael-John Milloy; Margaret E Hellard; Rachel Sacks-Davis; Paul M Dietze; Campbell Aitken; Malvina Aladashvili; Tengiz Tsertsvadze; Viktor Mravčík; Michel Alary; Elise Roy; Pavlo Smyrnov; Yana Sazonova; April M Young; Jennifer R Havens; Vivian D Hope; Monica Desai; Ellen Heinsbroek; Sharon J Hutchinson; Norah E Palmateer; Andrew McAuley; Lucy Platt; Natasha K Martin; Frederick L Altice; Matthew Hickman; Peter Vickerman
Journal:  Lancet Infect Dis       Date:  2018-10-29       Impact factor: 71.421

5.  Population estimation and harm reduction among people who inject drugs in Addis Ababa, Ethiopia.

Authors:  Negussie Deyessa; Bekele Senbete; Aman Abdo; Bernard M Mundia
Journal:  Harm Reduct J       Date:  2020-09-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.